These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6135061)

  • 21. TSH-receptor antibodies in hypothyroid Graves' disease.
    Konishi J; Kasagi K; Hidaka A; Takeuchi R; Iida Y; Nakamura H
    Exp Clin Endocrinol; 1991 May; 97(2-3):303-7. PubMed ID: 1680728
    [No Abstract]   [Full Text] [Related]  

  • 22. [The immune and nonimmune genesis of goiter].
    Grigorie D
    Endocrinologie; 1990; 28(3-4):95-106. PubMed ID: 1983320
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thyroid stimulating immunoglobulins, their role and significance in the pathogenesis of Basedow-Graves disease].
    Leövey A
    Orv Hetil; 1978 Aug; 119(33):2019-21. PubMed ID: 209384
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
    Gupta MK
    Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y; Kajita Y; Hamazu M; Nagata A
    Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune mechanisms in Graves' disease.
    Burman KD; Baker JR
    Endocr Rev; 1985; 6(2):183-232. PubMed ID: 2988930
    [No Abstract]   [Full Text] [Related]  

  • 27. Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy.
    Smith TJ
    Thyroid; 2002 Mar; 12(3):197-203. PubMed ID: 11952039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine exophthalmos: an immunologic aberration.
    Kaplan HJ
    Ophthalmic Semin; 1977; 2(2):203-46. PubMed ID: 327376
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current understanding of pathogenesis of Graves ophthalmopathy].
    Ando T; Eguchi K
    Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves' Disease: Analytical and Clinical Evaluation.
    Frank CU; Braeth S; Dietrich JW; Wanjura D; Loos U
    Horm Metab Res; 2015 Nov; 47(12):880-8. PubMed ID: 26079838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum and significance of autoantibodies reacting with the thyrotropin receptor.
    Zakarija M; McKenzie JM
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):343-63. PubMed ID: 3319587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSH receptor in endocrine autoimmunity.
    Otto E; Förster G; Kuhlemann K; Hansen C; Kahaly GJ
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S77-84. PubMed ID: 8828952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Occurrence of TSH receptor antibodies and thyroid microsomal antibodies in Graves-Basedow disease].
    Paunković N; Paunković D
    Med Pregl; 1995; 48(1-2):10-4. PubMed ID: 8657049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils.
    Weitzman SA; Stossel TP; Harmon DC; Daniels G; Maloof F; Ridgway EC
    J Clin Invest; 1985 Jan; 75(1):119-23. PubMed ID: 3838096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of assays for TSH-receptor antibodies.
    Bitcon V; Donnelly J; Kiaei D
    J Endocrinol Invest; 2016 Oct; 39(10):1195-6. PubMed ID: 27531172
    [No Abstract]   [Full Text] [Related]  

  • 38. Supervoltage orbital radiotherapy for Graves' ophthalmopathy.
    Donaldson SS; Bagshaw MA; Kriss JP
    J Clin Endocrinol Metab; 1973 Aug; 37(2):276-85. PubMed ID: 4198257
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
    Weetman AP; Cohen S; Gatter KC; Fells P; Shine B
    Clin Exp Immunol; 1989 Feb; 75(2):222-7. PubMed ID: 2784734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.